MARKET

TRIB

TRIB

Trinity Biotech Plc
NASDAQ

Real-time Quotes | Nasdaq Last Sale

1.380
0.000
0.00%
Closed 16:00 05/27 EDT
OPEN
1.450
PREV CLOSE
1.380
HIGH
1.450
LOW
1.350
VOLUME
93.40K
TURNOVER
93.54K
52 WEEK HIGH
3.480
52 WEEK LOW
0.8600
MARKET CAP
28.84M
P/E (TTM)
31.08
1D
5D
1M
3M
1Y
5Y
Trinity biotech receives European approval for rapid COVID-19 antigen test
Trinity Biotech (NASDAQ:TRIB) said on Friday it had achieved the European CE Mark or approval for its 10-minute Covid-19 antigen test.  This CE mark allows for use by healthcare professionals and
Seekingalpha · 05/20 15:54
Trinity Biotech Announces CE Mark Of Its 10-Minute Covid-19 Antigen Test
Trinity Biotech plc (NASDAQ:TRIB) has achieved a CE Mark for its 10-minute Covid-19 antigen test. This CE mark allows for use by healthcare professionals and trained users. The Company intends to launch the test
Benzinga · 05/20 13:21
Trinity Biotech Announces CE Mark of its 10-Minute Covid-19 Antigen Test
DUBLIN, Ireland, May 20, 2022 (GLOBE NEWSWIRE) -- Trinity Biotech plc (Nasdaq: TRIB) has achieved a CE Mark for its 10-minute Covid-19 antigen test. This CE mark allows for use by healthcare professionals and trained users. The Company intends to launch th...
GlobeNewswire · 05/20 13:20
Trinity Biotech Announces the Successful Closing of its Strategic Investment and Partnership With The MiCo Group of South Korea
DUBLIN, Ireland, May 03, 2022 (GLOBE NEWSWIRE) -- Trinity Biotech plc (Nasdaq: TRIB), a leading developer and manufacturer of diagnostic products for the point-of-care and clinical laboratory markets, today announced that it has closed its recently announc...
GlobeNewswire · 05/03 22:50
Trinity Biotech reports Q4 results
Trinity Biotech press release (NASDAQ:TRIB): Q4 GAAP EPADS of -0.4 cents. Revenue of $19.53M (-40.4% Y/Y). Gross profit for Q4, 2021 amounted to $7.2M equating to a gross margin of
Seekingalpha · 04/12 04:29
BRIEF-Trinity Biotech Reports $45 Mln Strategic Investment And Partnership With The MiCo Group of South Korea
reuters.com · 04/11 14:56
BRIEF-Trinity Biotech Announces Q4 And Fiscal Year 2021 Financial Results
reuters.com · 04/11 13:25
12 Health Care Stocks Moving In Monday's Pre-Market Session
Gainers Hoth Therapeutics (NASDAQ:HOTH) stock rose 156.5% to $1.58 during Monday's pre-market session. The market value of their outstanding shares is at $37.8 million.
Benzinga · 04/11 13:22
More
No Data
Learn about the latest financial forecast of TRIB. Analyze the recent business situations of Trinity Biotech Plc through EPS, BVPS, FPS, and other data. This information may help you make smarter investment decisions.
Analyst Rating

Based on 1 analysts

Strong Buy

Disclaimer: The analysis information is for reference only and does not constitute an investment recommendation.

100.00%Strong Buy
0.00%Buy
0.00%Hold
0.00%Under-perform
0.00%Sell
Analyst Price Target
The average TRIB stock price target is 4.000 with a high estimate of 4.000 and a low estimate of 4.000.
High4.000
Average4.000
Low4.000
Current 1.380
EPS
Actual
Estimate
-0.020.010.050.09
Q1 2021
Q2 2021
Q3 2021
Q4 2021
Q1 2022
Institutional Holdings
Institutions: 44
Institutional Holdings: 10.53M
% Owned: 50.38%
Shares Outstanding: 20.90M
TypeInstitutionsShares
Increased
5
2.60M
New
3
1.22M
Decreased
6
159.16K
Sold Out
2
26.38K
  • Performance
  • Asset Allocation
  • Dividend History
No Data
Industry
Medical Equipment, Supplies & Distribution
+1.86%
Healthcare Equipment & Supplies
+2.75%
Key Executives
Chairman/Director
Ronan O'Caoimh
Chief Financial Officer/Executive Director/Secretary
John Gillard
Executive Vice President
Fernando Devia
Senior Vice President
Sanjiv Suri
Chief Accounting Officer
Simon Dunne
Chief Information Officer
Eibhlin Kelly
Executive Director
James Walsh
Other
Terence Dunne
Director
Kevin Tansley
Non-Executive Director
Clinton Severson
Non-Executive Independent Director
James Merselis
No Data
No Data
About TRIB
Trinity Biotech Public Limited Company through its subsidiaries develops, acquires, manufactures and markets medical diagnostic products for the clinical laboratory and point-of-care (POC)segments of the diagnostic market. The Company's products are used to detect autoimmune, infectious and sexually transmitted diseases, diabetes and disorders of the liver and intestine. It operates through two segments: the Americas and Rest of World. Its products are classified as POC, emergency medicine, clinical laboratory and blood bank screening. Its POC brands include Uni-Gold and Recombigen. Emergency medicine diagnostics refer to its acute care testing, STAT labs, pre/post-operative units, physician office labs and the central laboratory. Trinity Biotech supplies clinical laboratory market with reagent products and other products through its clinical chemistry business.

Webull offers kinds of Trinity Biotech plc (ADR) stock information, including NASDAQ:TRIB real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, TRIB stock news, and many more online research tools to help you make informed decisions.

You can practice and explore trading TRIB stock methods without spending real money on the virtual paper trading platform.